Scientific article
English

Electronic monitoring of potential adverse drug events related to lopinavir/ritonavir and hydroxychloroquine during the first wave of COVID-19

First online date2021-04-08
Abstract

During Switzerland's first wave of COVID-19, clinical pharmacy activities during medical rounds in Geneva University Hospitals were replaced by targeted remote interventions. We describe using the electronic PharmaCheck system to screen high-risk situations of adverse drug events (ADEs), particularly targeting prescriptions of lopinavir/ritonavir (LPVr) and hydroxychloroquine (HCQ) in the presence of contraindications or prescriptions outside institutional guidelines. Of 416 patients receiving LPVr and/or HCQ, 182 alerts were triggered for 164 (39.4%) patients. The main associated risk factors of ADEs were drug-drug interactions, QTc interval prolongation, electrolyte disorder and inadequate LPVr dosage. Therapeutic optimisation recommended by a pharmacist or proposals for additional monitoring were accepted in 80% (n=36) of cases. Combined with pharmacist contextualisation to the clinical context, PharmaCheck made it possible to successfully adapt clinical pharmacist activities by switching from a global to a targeted analysis mode in an emergency context.

Keywords
  • COVID-19
  • Automation
  • Drug-related side effects and adverse reactions
  • Hospital
  • Medical informatics
  • Pharmacy service
Citation (ISO format)
SKALAFOURIS, Christian et al. Electronic monitoring of potential adverse drug events related to lopinavir/ritonavir and hydroxychloroquine during the first wave of COVID-19. In: European journal of hospital pharmacy, 2021. doi: 10.1136/ejhpharm-2020-002667
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Journal ISSN2047-9956
193views
0downloads

Technical informations

Creation22/02/2022 15:22:00
First validation22/02/2022 15:22:00
Update time03/02/2025 11:17:01
Status update03/02/2025 11:17:01
Last indexation03/02/2025 11:25:35
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack